Apellis Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $712k | 31k | 22.64 |
| 2024-12-31 | $250k | 7.8k | 31.91 |
| 2024-09-30 | $824k | 29k | 28.83 |
| 2022-03-31 | $879k | 17k | 50.80 |
| 2021-06-30 | $1.1M | 17k | 63.22 |
| 2021-03-31 | $358k | 8.3k | 42.89 |
| 2020-12-31 | $355k | 6.2k | 57.12 |
| 2020-09-30 | $467k | 16k | 30.17 |
| 2019-12-31 | $320k | 11k | 30.59 |